1. Ethos:
Axis Direct maintains its ‘Buy’ rating on this luxury watch retailer, with a target price of Rs 3,360, an upside of 28.2%. Analysts Suhanee Shome and Urmi Shah are positive on Ethos as it opens new stores, widens price points, and scales its in-house brand, Favre Leuba. Management sees substantial headroom in India’s luxury market and aims to expand revenue tenfold over the next decade.
Ethos plans to triple its boutique count to 300 over the next five to six years. It is rolling out tailored formats for distinct customer segments: ‘Hour Studio’ targets watches priced between Rs 25,000 and Rs 2 lakh, while ‘Ethos Haute Horology’ caters to ultra-luxury pieces above Rs 50 lakh. The firm also plans to produce 8,000 Favre Leuba watches this year and double capacity within two years.
Shome and Shah note that earlier challenges around hiring trained staff and finding suitable premium locations have eased. They anticipate new store rollouts, same-store sales growth, pre-owned watches, and luxury accessories to drive performance. Analysts forecast revenue to climb 31.8% annually and net profit to surge 72.2% annually through FY29.
2. Healthcare Global Enterprises (HCG):
Prabhudas Lilladher maintains its ‘Buy’ rating on this hospital chain, with a target price of Rs 820, an upside of 20.5%. Analysts Param Desai and Sanketa Kohale remain confident in HCG as patient footfalls rise and bed capacity expands. Management targets mid-teens revenue growth, alongside a 3–5% annual increase in revenue per patient.
HCG will invest around Rs 550 crore to add 900 beds by FY30, expanding existing hospitals by 550 beds and adding 350 beds through new facilities. The company is pursuing expansion across Mumbai, Ahmedabad, Coimbatore, and Punjab. It also plans to acquire 120–150-bed hospitals in underserved cancer-care regions. Management estimates EBITDA margins to climb from 18.3% in FY26 to over 20% within three years. North Bengaluru hospital turning profitable, lower purchasing costs and more efficient spending on sales and marketing will drive margins higher.
Desai and Kohale expect higher bed occupancy, lower procurement costs, and an increasing share of insurance and cash-paying patients to boost profitability. Investment backing from KKR will further sharpen operational efficiency. Analysts forecast operating profit to grow 24% annually over FY27–28, up from 19% during FY24–26.
3. Shriram Finance:
Motilal Oswal retains its ‘Buy’ rating on this non-banking lender with a target price of Rs 1,220, implying an upside of 26.4%. Analysts Abhijit Tibrewal and Nitin Aggarwal expect earnings to improve as Shriram Finance expands beyond its traditional commercial vehicle-finance business, lowers borrowing costs and uses its large branch network more efficiently.
MUFG Bank’s purchase of a 20% stake gives Shriram Finance healthy capital to fund growth over the next four to five years. Lower funding costs enable it to expand into new vehicle financing, helping existing borrowers move from used to new vehicles. The relationship with MUFG could create potential partnerships with Japanese giants such as Toyota, Denso and Honda, which should generate opportunities in areas such as equipment leasing, rural lending and financing for small businesses.
Management wants vehicle loans, small-business loans and gold loans to each contribute around 20% of total loans over the next three years. Shriram Finance can also use its large customer base to offer more products to existing borrowers as their financing needs change. Tibrewal and Aggarwal believe this should improve customer retention and help the company expand into a broader retail lender rather than remain focused mainly on commercial vehicles.
4. Cyient DLM:
ICICI Direct maintains its ‘Buy’ rating on this electronics manufacturing services company, with a target price of Rs 1,100, an upside of 17.2%. Analysts Jaymin Trivedi and Kirankumar Choudhary favour the stock as the company expands into semiconductor equipment, AI data centres, and robotics. Surging investments in India's chip ecosystem and rising AI infrastructure spending boost demand for its data-centre electronics. In robotics, the firm plans to build high-reliability components and testing systems.
Management targets up to 30% annual revenue growth over the medium term, backed by a strong order pipeline. In Q1FY27, its order book hit Rs 2,599 crore, over double its FY26 revenue. The company has also identified a $1 billion pipeline of design orders through FY34. Higher production volumes and premium products should lift EBITDA margins from ~10% to around 12% across FY27–29.
Trivedi and Choudhary expect steady order wins, faster project execution, and new business lines to power future earnings. They project revenue to grow at a 27.9% CAGR over FY27–28, with operating profit and net profit jumping 40% and 41% annually.
5. HDFC Bank:
ICICI Securities maintains its ‘Buy’ rating on this private-sector bank, with a target price of Rs 920, an upside of 29.3%. Analysts Jai Prakash Mundhra and Amansingh Sahajsinghani believe Anup Bagchi’s appointment as MD & CEO clears leadership uncertainty and offers an opportunity for a fresh strategic direction.
The bank’s leadership aims to prioritise cutting funding costs, reviving low-cost CASA deposit growth, and boosting returns across its extensive branch network. Analysts add that management must also strengthen technology infrastructure and internal governance. Bagchi’s broad financial services background will help HDFC Bank cross-sell products and attract deposits across group companies.
HDFC Bank has already expanded its deposits market share from 9.5% in FY22 to 11.8% in FY26. Mundhra and Sahajsinghani project advances and deposits to grow 13.2% and 15.8% annually over FY27–28. Over the same period, they expect return on equity (RoE) to rise from 13.8% to 14.5% and net interest margins to improve from 3.3% to 3.5%.
Note: These recommendations are from various analysts and are not recommendations by Trendlyne.
(You can find all analyst picks here)